Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-01-21+230,000→ 230,000 totalExercise: $2.77Exp: 2035-01-20→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.